However, CD24 expression was significantly downregulated in colon adenocarcinoma (COAD), head and neck squamous cell carcinoma (HNSC), kidney renal clear cell carcinoma (KIRC), and thyroid carcinoma (THCA) (Figure 2A). Here, CD24 is linked to head and neck squamous cell carcinoma.